BRIEF published on 05/02/2025 at 15:27, 1 year 1 month ago Sanofi increases its stake in Innate Pharma Capital Actions Crossing Thresholds Sanofi Innate Pharma
PRESS RELEASE published on 05/02/2025 at 15:22, 1 year 1 month ago Franchissement de seuils Déclaration de franchissement de seuils par Sanofi pour Innate Pharma via augmentation de capital Augmentation De Capital Franchissement De Seuils Sanofi Innate Pharma
BRIEF published on 04/29/2025 at 21:05, 1 year 1 month ago Innate Pharma Presents Promising Preclinical Data for IPH4502 at AACR 2025 Preclinical Data Innate Pharma IPH4502 Nectin-4 Antibody Drug Conjugate
BRIEF published on 04/29/2025 at 21:05, 1 year 1 month ago Innate Pharma présente des données précliniques prometteuses pour IPH4502 à l'AACR 2025 Innate Pharma Données Précliniques Conjugué Anticorps-médicament IPH4502 Nectine-4
PRESS RELEASE published on 04/29/2025 at 21:00, 1 year 1 month ago Inside Information / Other news releases Innate Pharma presents preclinical data for IPH4502, a Nectin-4 targeting ADC, showing superior anti-tumor efficacy in multiple cancer models at AACR 2025 Annual Meeting Preclinical Data Innate Pharma IPH4502 AACR 2025 Nectin-4 ADC
PRESS RELEASE published on 04/29/2025 at 21:00, 1 year 1 month ago Informations privilégiées / Autres communiqués Innate Pharma présente les données précliniques prometteuses d'IPH4502, un conjugué anticorps-médicament innovant ciblant Nectine-4, au congrès annuel de l'AACR 2025 Préclinique Innate Pharma Conjugué Anticorps-médicament IPH4502 AACR 2025
BRIEF published on 04/24/2025 at 07:40, 1 year 2 months ago Innate Pharma Secures €15M Sanofi Investment Capital Increase Innate Pharma Sanofi Investment BCMA ANKET Biotech Partnership
BRIEF published on 04/24/2025 at 07:40, 1 year 2 months ago Innate Pharma obtient un investissement de 15 millions d'euros auprès de Sanofi Augmentation De Capital Innate Pharma BCMA ANKET Investissement Sanofi Partenariat Biotechnologique
PRESS RELEASE published on 04/24/2025 at 07:35, 1 year 2 months ago Inside Information / Other news releases Innate Pharma announces €15M investment by Sanofi to strengthen collaboration and support pipeline execution. Closing of the capital increase expected on April 25, 2025 Investment Collaboration Sanofi Innate Pharma Pipeline Execution
PRESS RELEASE published on 04/24/2025 at 07:35, 1 year 2 months ago Informations privilégiées / Autres communiqués Innate Pharma annonce un investissement de 15 millions d’euros de Sanofi pour renforcer leur partenariat stratégique. L'augmentation de capital sera utilisée pour soutenir le développement de leur portefeuille Investissement Partenariat Augmentation De Capital Sanofi Innate Pharma
Published on 06/27/2026 at 00:00, 5 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 hour 5 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 hour 15 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 1 hour 50 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/26/2026 at 23:36, 29 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 29 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 37 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 19:50, 4 hours 15 minutes ago Name Change Completed for C Capital's Swiss Listed Entity, Ticker Symbol CCAP Goes Live
